Adenocarcinoma
|
A carcinoma characterized by glandular architecture and/or secretary differentiation
|
Adenoma
|
A benign epithelial neoplasm usually showing glandular architecture. In some cases, can be considered precancerous
|
AMACR
|
Α-methylacyl-CoA racemase, an enzyme over expressed in some prostatic neoplasia that can be targeted with antibody staining
|
Anaplasia
|
The condition of being poorly differentiated or lacking differentiation • common characteristic of malignant cells • often with marked or variable nuclear enlargement.
|
Anticoagulant
|
Inhibits fibrin clotting
|
Antithrombic
|
Inhibits platelet plugging
|
Apoptosis
|
An active, highly regulated, ATP-dependent process of cellular self-destruction that involves individual cells. • Can be pathologic • Important to development
|
Atherosclerosis
|
A general term for diseases associated with "hardening" or thickening of the walls of arteries
|
Atrophy
|
A decrease in tissue mass resulting from a decrease in cell number, cell size, or both
|
BPH
|
Benign prostatic hyperplasia. Can cause elevated PSA as well as a positive digital rectal exam finding. May impinge urethra, causing symptoms similar to prostate cancer
|
Carcinoma
|
A malignant neoplasm of epithelial origin. Characterized by invasion or metastasis
|
Carcinoma in situ
|
A pre-malignant condition that has the cytological features of malignancy but is confined to the epithelium. Must have full-thickness cytological atypia and can be considered the end-point of severe dysplasia
|
Cardiogenic shock
|
Shock resulting from acute severe failure of myocardial muscle function
|